AbbVie Studies Show Aesthetic Treatments Improve Facial Appearance Satisfaction in GLP-1 Users

By Public Technologies
  • AbbVie's Allergan Aesthetics reported improved facial appearance satisfaction in two Phase 4 studies of adults taking GLP-1 medications for weight loss.
  • HARMONY IN DIVERSITY combined fillers, a neurotoxin and skincare, significantly improving satisfaction with facial appearance, skin quality and psychosocial function.
  • HALO interim results showed high satisfaction with facial appearance following filler treatment, including natural-looking results.
  • Most treatment-related adverse events in both studies were mild and nonserious.
  • Results were presented at the American Society for Dermatologic Surgery annual meeting, held Nov. 5-8, 2026, in San Diego.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611081245PR_NEWS_USPR_____CG91311) on November 08, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.